KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $5.98.

  • Amgen's EPS (Basic) rose 1347.25% to $5.98 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.03, marking a year-over-year increase of 6514.58%. This contributed to the annual value of $7.62 for FY2024, which is 3936.0% down from last year.
  • According to the latest figures from Q3 2025, Amgen's EPS (Basic) is $5.98, which was up 1347.25% from $2.66 recorded in Q2 2025.
  • Amgen's EPS (Basic)'s 5-year high stood at $5.98 during Q3 2025, with a 5-year trough of -$0.21 in Q1 2024.
  • Moreover, its 5-year median value for EPS (Basic) was $2.85 (2021), whereas its average is $2.87.
  • Per our database at Business Quant, Amgen's EPS (Basic) tumbled by 10394.72% in 2024 and then surged by 163333.33% in 2025.
  • Over the past 5 years, Amgen's EPS (Basic) (Quarter) stood at $3.36 in 2021, then fell by 10.12% to $3.02 in 2022, then crashed by 52.32% to $1.44 in 2023, then dropped by 18.92% to $1.17 in 2024, then soared by 412.16% to $5.98 in 2025.
  • Its last three reported values are $5.98 in Q3 2025, $2.66 for Q2 2025, and $3.22 during Q1 2025.